–
Indaptus Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.73
FY22:
−14.9
FY23:
−16.4
FY24:
−15.4
FY25:
−19.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.73
FY22:
−14.9
FY23:
−16.4
FY24:
−15.4
FY25:
−19.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.71
FY22:
−14.3
FY23:
−15.4
FY24:
−15.0
FY25:
−20.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−7.71
FY22:
−14.3
FY23:
−15.4
FY24:
−15.0
FY25:
−20.8
All amounts in millions USD